Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma.

Block, Timothy; Zezulinski, Daniel; Kaplan, David E; Lu, Jingqiao; Zanine, Samantha; Zhan, Tingting; Doria, Cataldo; Sayeed, Aejaz

Block, Timothy; Zezulinski, Daniel; Kaplan, David E; Lu, Jingqiao; Zanine, Samantha; Zhan, Tingting; Doria, Cataldo; Sayeed, Aejaz.

Afiliación

Block T; Department of Translational Medicine, Baruch S. Blumberg Institute, Doylestown, PA, United States.
Zezulinski D; Department of Translational Medicine, Baruch S. Blumberg Institute, Doylestown, PA, United States.
Kaplan DE; Division of Gastroenterology and Hepatology, University of Pennsylvania Perelman School of Medicine and The Corporal Michael J. Crescenz Veterans Administration Hospital, Philadelphia, PA, United States.
Lu J; Ray Biotech Life Inc., Peachtree Corners, GA, United States.
Zanine S; Department of Mechanical Engineering, Pennsylvania State University, PA, United States.
Zhan T; Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia PA, United States.
Doria C; CHS Liver and Pancreas Centers of Excellence, Capital Health Cancer Center, One Capital Way, Pennington, NJ, United States.
Sayeed A; Department of Translational Medicine, Baruch S. Blumberg Institute, Doylestown, PA, United States.

Front Oncol ; 12: 963641, 2022.

Article en En | MEDLINE | ID: mdl-36582804

Palabras clave

HCC surveillance and early detection; circulating mRNA variants; extracellular vesicles; hepatocellular carcinoma; liver cirrhosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Screening_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google